JHS Svendgaard Laboratories Limited (NSE:JHS)
India · Delayed Price · Currency is INR | Market Cap | 791.90M -16.5% |
| Revenue (ttm) | 1.11B +17.6% |
| Net Income | -18.87M |
| EPS | -0.21 |
| Shares Out | 87.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 165,025 |
| Open | 9.01 |
| Previous Close | 9.06 |
| Day's Range | 8.16 - 9.24 |
| 52-Week Range | 6.26 - 13.90 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |
About NSE:JHS
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India. [Read more]
Financial Performance
In fiscal year 2026, NSE:JHS's revenue was 1.05 billion, an increase of 13.93% compared to the previous year's 922.91 million. Losses were -19.22 million, -90.26% less than in 2025.
Financial StatementsNews
JHS Svendgaard completes land acquisition in Jammu & Kashmir for business expansion; Stock drops 5%
JHS Svendgaard recently informed exchanges that it has acquired and completed the registration of sale deeds for the land of 18 Kanal 06 Marla in Hiranagar Kathua, Jammu & Kashmir, for the purpose of ...